What are the results of the Antinuclear Antibody (ANA) test?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Ana test results should be interpreted with caution, considering the patient's symptoms, medical history, and the fact that a positive result does not necessarily mean an autoimmune disease is present, as noted in the study by Agmon-Levin et al. 1. When interpreting ANA test results, it is essential to consider the titer and pattern of antibodies, as well as the clinical context, to determine the likelihood of an autoimmune disorder.

  • A positive ANA test result indicates the presence of antibodies that may attack the body's own tissues, suggesting a possible autoimmune disorder such as lupus, rheumatoid arthritis, or Sjögren's syndrome.
  • However, a positive result does not necessarily mean an autoimmune disease is present, as some healthy individuals can have positive ANA tests, with a specificity of 74.7% for SLE when using a 1:80 cut-off point, as reported in the study by 1.
  • The use of a 1:160 dilution as the cut-off point can increase the specificity to 86.2%, while maintaining an appropriate sensitivity, as noted in the study by 1.
  • If the ANA test is negative, it generally suggests that an autoimmune disease is less likely, though some people with autoimmune conditions can still have negative results.
  • It is crucial to follow up with a doctor to discuss specific results, as they may recommend additional testing, such as specific antibody tests or clinical evaluations, to reach a diagnosis, as emphasized in the study by 1. Early diagnosis and treatment of autoimmune conditions can help manage symptoms and prevent complications.
  • The EULAR/ACR 2019 classification criteria recommend ANA detection using the IFI or a solid-phase ANA screening immunoassay (SPA) with at least equivalent performance, as noted in the study by 1.
  • However, the lack of precision in the concept "equivalent performance" can lead to the use of SPAs with insufficient specificity in SLE screening, highlighting the need for standardization and clear reporting of methods used, as discussed in the study by 1.

From the Research

Ana Test Result

  • The ana test result is often used in conjunction with other tests, such as anti-dsDNA, to diagnose and monitor systemic lupus erythematosus (SLE) 2.
  • Anti-dsDNA antibodies are a key biomarker for SLE and are often used to diagnose and monitor the disease 3, 4.
  • The sensitivity and specificity of ana and anti-dsDNA tests can vary depending on the population being tested, with higher specificity seen in healthy controls compared to patients with multiple medical problems 2.
  • Anti-dsDNA antibodies have been shown to be associated with active lupus nephritis and SLE disease activity, and can be used as a marker for monitoring disease activity 4.
  • The use of anti-dsDNA antibodies as a classification criterion and diagnostic marker for SLE has been questioned due to the complexity of the antibody and its varying specificities 5.
  • Different studies have shown that ana and anti-dsDNA tests can have high sensitivity and specificity in patients with SLE, but the results should be interpreted with caution in patients with multiple medical problems 2, 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.